Dare Bioscience, Inc.
DARE· Nasdaq
DAREDare Bioscience, Inc.
Released May 13, 2025, after the close
10-Q filed May 13, 2025, 43 days after period end · 0001401914-25-000022
| Metric | Q1 2025 | Q1 2024 | Q1 2023 | Q1 2022 |
|---|---|---|---|---|
| Revenue | $25.43K | $9.30K | $0.00 | — |
| Net Income | -$4.38M | -$6.76M | -$8.04M | -$8.40M |
| EPS Diluted |
Dare Bioscience, Inc. · CIK 1401914 · Engraved from SEC EDGAR
| -$0.50 |
| -$0.81 |
| -$0.09 |
| -$0.10 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
